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Prostate cancer is the most common cause of cancer death in men, aged 85 and over. Androgen 
receptor, a single polypeptide with three functional domains is very important during initiation and 
progression of the disease. In this study, a DNA intercalating agent, acridine is linked to the 
testosterone via a polyamine linker to obtain a compound with trifunctional characteristics, where the 
acridine intercalates the DNA, the polyamine linker binds the phosphoryl groups of the DNA backbone 
and the testosterone moiety binds into the AR ligand binding domain, with which its DNA binding 
domain is bound already to the DNA. This trifunctional compound and related derivatives have been 
synthesized and tested against androgen dependent- and androgen independent- prostate cancer cell 
lines and they have demonstrated to be cytotoxic at the micromolar concentrations. 
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INTRODUCTION 
 
Prostatic adenocarcinoma is the most common cause of 
cancer death in men, aged 85 and over (Crawford, 2009). 
The tumour is androgen dependent, due to the presence 
of androgen receptor (AR). AR is a single polypeptide 
with three functional domains; an amino terminal domain 
and a DNA binding domain linked by a hinge region to a 
ligand binding domain. Although these domains are 
different, they influence each other’s activity. Androgens, 
mainly testosterone, binds the AR through the ligand 
binding domain which consequently binds to the DNA to 
start the expression of the proteins important for biologi-
cal functions of the organism (Nahoum and Bourguet, 
2007). Polyamines are small amines containing aliphatic 
molecules, which are water-soluble. Polyamines are 
positively charged at physiological pH, with amino groups 
separated by 3 or 4 carbon atoms. They are found 
ubiquitously in all living cells and the most common 
naturally occurring are putrescine, spermidine and 
spermine (Figure 1). These polyamines are biosynthe-
sized mainly in most cell types where they are necessary 
for optimal growth and replication of  all  cells  by  influen- 
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cing transcriptional and translational stages of protein 
synthesis and by altering intracellular levels of free 
calcium, hence suggesting their roles as intracellular 
messengers and stabilizers of conformations of nucleic 
acids (Pegg, 1998). Cellular polyamines originate mainly 
from intracellular biosynthesis (endogenous) or by uptake 
via transporters from the extracellular environment 
(exogenous). Amongst the three naturally occurring 
polyamines, spermine has a higher cellular uptake in 
prostate cancer cell lines than in other types of 
malignancies (Srinath et al. 2002). Spermine blocks 
prostatic tumour proliferation in vitro and prevents 
subcutaneous tumour progression in vivo (Cheng et al., 
2001). These effects, mainly active transport, DNA 
binding and high cellular uptake of spermine in prostate 
cells, make it an important tool in drug design for prostate 
cancer chemotherapy. Acridine is a tricyclic planar 
compound and its derivatives intercalate DNA. This 
intercalation inhibits DNA replication and translation 
which eventually leads to cellular death which is 
enhanced by the presence of a side chain such as alkyl 
chains and polyamines at C-9. However, intercalation 
alone cannot account for the pronounced cytotoxicity 
shown by these amino acridine derivatives but rather the 
formation of DNA-protein cross-links and DNA breaks 
(Filipski  et al., 1977)  by  block  topoisomerase  I  and  II,  
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Figure 1. Naturally occurring polyamines. 
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Figure 2. Designed trifunctional compound. 
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Figure 3. Acridine derivatives synthesized. 
 
 
enzymes responsible for DNA cleavage during helix 
formation. The target compounds comprised of three 
parts: acridine and its derivatives linked to a polyamine 
and the third fragment comprised of an androgen were 
synthesized. It was expected that the planar structure of 
the acridine would interact with DNA base pairs, while the 
polyamine was expected to bind to the negatively 
charged phosphate DNA backbone and also to bind DNA 
bases. It was anticipated that when the androgen moiety 
is attached to the acridine-spermine conjugate, binds to 
the AR receptors to form a complex, the whole molecule 
will then be pulled onto the DNA where it will bind 
strongly thus inhibiting further biological activities (Figure 
2). 
 
 
METHODOLOGY 
 
Synthesis  
 
Several acridine derivatives were synthesized using different 
approaches depending on the nature and position of various 
functional groups. Selected Acridine derivatives are shown in 
Figure 3. The synthesis started with a commercially-available 
unsubstituted acridone 1 that was converted to the chloride 2 at C-9  
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Scheme 1. a) SOCl2, DMF 120°C, 96%. b) f1 20°C, 5 h, 
95%. 
 
 
NH2
OH
O
Br
OMe
N
H OMe
CO2H
N
H
O
OMe
N
Cl
OMe
+
a
b c
4
5 6
 
 
Scheme 2. a) Cu, CuO, K2CO3, 145°C, 60%. b) 
polyphosphoric acid, 120°C, 67%. c) SOCl2, 120°C, 84%. 
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Scheme 3. a) CuO, DMF, 120ºC, 24 h, 56% b) NaOH, H2O, 
100ºC, 6 h, 86%, c) SOCl2, 120ºC, 2h 
 
 
by chlorination with thionyl chloride. Due to the unstability of the 
chloride it had to be converted into  a  phenoxy  derivative  3  which 
resulted in a stable compound that could be stored for a longer time 
(Scheme 1). 
The synthesis of a methoxy substituted acridone began with the 
reaction of anthranilic acid and bromoanisole in the presence of 
copper and copper oxide as catalysts. The reaction was heated at 
145°C and a relatively good yield was obtained when a black 
amorphous solid was purified using a large volume of methanol 
containing ammonia in the column chromatography. Cyclization of 
the resulting acid 4 was accomplished by heating the reactant with 
polyphosphoric acid for about an hour after which the reaction 
mixture was poured into hot water and cooled for 24 h to produce 
acridone 5 as a yellow precipitate that was pure and ready for 
further reaction. This methoxyacridone 5 was chlorinated using 
thionyl chloride (Scheme 2). The chloride 6 was reacted 
immediately with a protected polyamine. For the synthesis of 
methoxyacridine-9-carboxylic acid, (Scheme 3) isatin was reacted 
with bromoanisole in DMF with CuO as a catalyst to give product 7   
604   Afr. J. Pharm. Pharmacol. 
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Scheme 4. a) DIPEA, DMF, Cu(OAc)2, 12 h, 120 ºC, 75%. b) 
polyphosphoric acid, 120ºC, 3 h, 70%. c) i) SOCl2, 80ºC 1 h, 
95% ii) N, N-dimethylethylene diamine, CH2Cl2, 0ºC. 
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Scheme 5. a) 0ºC, dichloromethane, N, N-
dimethylethylene diamine, 64% overall. 
 
 
 
as a dark brown solid (Keshava et al., 2005). Cyclization to give the 
4-methoxyacridine-9-carboxylic acid 8 was successfully achieved 
by dissolving the product 7 in aqueous sodium hydroxide solution 
and then heating (Allais, 1982). The desired product 8 was isolated 
with an excellent yield. 4-Methoxyacridine-9-carboxylic acid 8 was 
reacted with thionyl chloride to obtain an acyl chloride 9, which 
wasreacted in further steps without isolation. 
The other set of acridine derivatives prepared was those with a 
carboxamide substituent at C-4 with or without another group at C-
5. The precursors for this reaction were chlorobenzoic acid and 
aminobenzoic acid or its methyl derivative. Anthranilic acid was 
reacted with 2-chlorobenzoic acid using cupric acetate and DIPEA 
as catalysts. The diacid 10 was obtained as a black powder that 
was purified by recrystallization. Cyclization was achieved by 
heating 10-11 in PPA. The resulting acridonic acids 12-13 were 
bright yellow in colour and isolated with the good yields of 60 and 
78% respectively in comparison with literature yields of 70 and 80% 
respectively (Atwell, 1987). The PPA was removed by pouring the 
hot reaction mixture into vigorously stirred boiling water and the 
product precipitated out upon cooling (Scheme 4). Heating the 
acids 12-13 with thionyl chloride resulted in chlorination at C-9 and 
formation of an acyl chloride. Once the products 14-15 were 
obtained, they were reacted directly with the N, N-dimethylethylene 
diamine in the next step to obtain 16-17 (Scheme 5). 
Unreacted amine and by-products were removed by washing the 
reaction mixture with water. The organic phase was recovered and 
evaporation of the solvent gave the product as an orange solid. 
This was used in subsequent reactions without further purification  
due to its instability. Boc protection  was  carried  out  using  a  one- 
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Scheme 6. a) Ethyl TFA, -78ºC THF, CH3OH, 30 min. b) di-tert 
butyldicarbonate, CH3OH, 30 min. c) NH3. 
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Figure 4. di-Bocspermine. 
 
 
pot procedure, whereby one of the primary amino groups was first 
protected with the trifluoroacetyl group by reaction with ethyl 
trifluoroacetate (Geall et al., 2000). The reaction was started at -
78ºC to limit acylation to one primary amine. Ethyl trifloroacetate 
was added drop wise over a period of 30 min. to a solution of the 
acid. After this stage, the temperature was raised to 0ºC after which 
a solution of di-tert-butyldicarbonate was added drop wise over 30 
min. Aqueous ammonia was added to increase the pH to 11 to 
enable the cleavage  of  the  trifloroacetyl  group  and  generate  tri- 
protected spermine 18. Purification was done by column 
chromatography to give the pure product as colourless oil in 40% 
yield (Scheme 6). Di-Boc spermine 19 (Figure 4) was prepared by a 
modifying the method whereby the equivalents of ethyl 
triflouroacetate were doubled and the cleavage of the N-trifluoroacyl 
groups was facilitated by aqueous lithium hydroxide rather than 
ammonia. Linking a protected spermine to an acridine is relatively 
straight forward and very good yields were obtained. 9-
Chloroacridine 2 as well as 9-phenoxyacridine 3 was used in 
subsequent amination of C-9. 
The synthesis of the amine was carried out by heating a 
protected amine with an activated acridine derivative 2 or 3 in 
phenol at about 120°C overnight. Phenol was removed by washing 
a dichloromethane solution of the reaction mixture with an aqueous 
solution of sodium hydroxide. The organic phase was recovered, 
evaporated and the residue was subjected to column 
chromatography. These tri-Boc spermine-acridine conjugates were 
isolated as yellow viscous oils in high yields. Deprotected spermine-
acridine conjugates 24-27 were prepared by dissolving the N-
protected derivatives 20-23 in dichloromethane and adding excess 
TFA. Purification of these deprotected amines was carried out using 
column chromatography using DOWEX, a cation exchange resin, 
as a stationary phase and isopropanol and water as mobile phase 
for a gravity column. The deprotected residue was dissolved in 
50:50 water and isopropanol and then adsorbed onto the resin. 
Hydrochloric acid was passed through the column in the eluotropic  
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Scheme 7. a) Phenol, 120ºC, 16 h, 75%. b) CH2Cl2, TFA, 1 h, 80%. 
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Scheme 8. a) NaEtSH, 100ºC, 3 h, 76%. 
 
 
 
series of 1, 2, 2.5 and 4M. On evaporation of the solvents, the 
yellow hydrochloride salts 24-27 were obtained, and these products 
were polar (Scheme 7). The hydroxyl deprotection of the 
methoxyacridine conjugate 27 was executed successfully by 
reacting the conjugate with sodium ethanethiolate at a temperature 
of 100°C for 3 h in DMF (Scheme 8) and compound 31 was obtain 
in an excellent yield (Linderberg et al., 2004). 
 
 
Amide linked conjugates 
 
The route followed was the conversion of the acid functionality to 
the acyl chloride 33 by the reacting it with thionyl chloride. The 
resulting acyl chloride was reacted immediately with protected 
spermine 18 in the presence of catalytic quantities of DIPEA for 2 h, 
to avoid the deprotection of tri-Boc-spermine by hydrochloric acid 
generated (Scheme 10). Deprotection of the amide conjugates 34 
and 35 was accomplished using the standard conditions and 
purification was done on silica gel (Scheme 9). 
Di-Boc-spermine    19   and    androsterone 33   (Figure 5)   were  
reacted to in molar equivalents limited to a 1:1 ratio to ensure 
reaction exclusively at one primary amino group while sparing the 
other for further reaction with the acridine intermediates. 
Borane-Pyridine (BAP) was used as a reducing agent (Rastogi et 
al.,  2006) which worked very well to produce 34 in a yield of 60%. 
The free amine of the androsterone-di-Boc-spermine conjugate 
34 was reacted successfully with phenoxy acridine 3. The work up 
was done as in previous experiments of that nature to obtain the 
trifunctional 35 as yellow-coloured oil (Scheme 11). Deprotection of 
35 was done as usual with TFA and purification by recrystallization 
by warming the residue with acetonitrile and leaving the mixture 
undisturbed overnight gave product 36 as a yellow solid which was 
recrystallized from ethanol (Scheme 11). 
 
 
Cytotoxicity testing 
 
The cell lines employed in this study were LNCaP and PC3 cells, 
both of which are derived from human prostatic sarcoma. Both cell 
lines  were  routinely  maintained  as  monolayer  cultures  in  RPMI  
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Scheme 9. a) Coupling agent (DCC, HOBt, or EDAC). 
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Figure 5. Androsterone and di-Bocspermine. 
 
 
 
1640 medium supplemented with 10% foetal calf serum, sodium 
pyruvate (2mM), L-glutamine (2mM), penicillin/streptomycin (50 
IUml-1/50µgml-1) and buffered with HEPES (25mM). Both cell lines 
were routinely maintained at 37ºC in a humidified atmosphere 
containing 5% CO2. 
All test compounds were dissolved in DMSO at 10mg/ml and 
stored at -20ºC. Chemosensitivity was assessed using MTT assay 
as follows: 
Cells were seeded into 96 well plates at 1 x 103 cells per well 
(with the exception of the first lane of the plate which contained 
media only that served as the blank for spectrophotometry) in a 
volume of 100 µl complete RPMI 1640 medium. A range of drug 
dilutions were prepared at 2 times the final concentration desired 
and 100 µl of each drug concentration added to the plate (8 wells 
per drug concentration). The highest drug concentration tested was 
10 µg/ml and the final DMSO concentration was 0.1% in all cases. 
Following 6 day incubation at 37ºC, 20 µl of MTT (5 mg/ml) was 
added to each well and incubated for a further 4 h at 37ºC. Media 
plus MTT (200 µl) was carefully removed from each well and 150 µl 
of the DMSO was added to each well to dissolve formazan crystals. 
The absorbance of the resulting solution was determined at 540 nm 
using an ELISA plate reader and the results were expressed in 
terms of percentage survival as follows: 
% Survival = (Absobance of treated wells – blank)   x 100 
          (Absobance of control well – blank)  
 
Each assay was repeated in triplicate and dose response curves 
constructed by plotting % survival against drug concentration. IC50 
values were determined which is defined as the concentration of a 
drug required to kill 50% of cells. 
 
 
RESULTS AND DISCUSSION 
 
Towards the synthesis of functionalized trifunctional 
compounds, several intermediates where made. The 
synthesis of substituted acridones was initiated from their 
respective precursors and the amination step using 
Johnson-Ullman reaction proceeded smoothly. Also, the 
cyclization reactions involving the heating and use of 
PPA had some separation problems for some acridones 
due to the high viscosity of the acid. According to the 
literature, PPA was supposed to be removed by pouring 
the  hot  reaction  mixture  into  vigorously  stirred  boiling 
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Scheme 10. a) SOCl2, 80ºC, 1 h, 95%. b) CH2Cl2, DIPEA, rt, 2 h, 50% 
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Scheme 11. a) BAP, dry. THF/MeOH, RT, 12 h, Acetic acid, 60%. b) 9-
Phenoxyacridine, phenol, 120ºC, 70%. c) TFA, CH2Cl2, 2 h, RT, 90% 
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water and the product was expected to precipitate out 
upon cooling. This however, produced low yields in the 
range of 25% at first because not all the PPA reacted 
with water and, due to its high viscosity, it could not be 
filtered through sintered glass thus trapping the product in 
an oily mixture. The workup was modified and a dilute 
solution of ammonia in methanol and dichloromethane 
was added to the reaction mixture to produce ammonium 
phosphates which crystallized out, leaving the acridones 
in solution. For acridones 12 and 13, the presence of a 
ketone peak at 177.5 ppm and upfield shift of a carboxylic 
acid signal at 170.0 ppm in the 13C NMR spectrum was a 
confirmation. The 1H NMR spectrum showed signals for 
the aromatic hydrogens at around 8-7 ppm and a 
broad singlet for the carboxylic acid peak was at 7.37 
ppm. The methyl substituted acridone 13 had a similar 
13C NMR spectrum with signals in the expected chemical 
shift regions. The signal appeared at 175.8 ppm, the 
carboxylic acid functionality peak was at 171.4 ppm and 
the signal for the methyl group was at 19.4 ppm. Analysis 
of the 1H NMR spectrum showed the carboxylic acid 
proton at 12.00 ppm while the methyl protons were at 
2.34 ppm. The double chlorination of the ketone at C-9 
and the carboxylic acids 12-13 at C-4 was carried out at 
the same time using thionyl chloride. Because the two 
functional groups reacted at different rates it was 
necessary to ensure that both the ketone and the acid 
functionalities had reacted before the reaction was 
quenched. An optimum reaction temperature was found 
because overheating resulted in decarboxylation of the 
starting material or the resultant product thus producing 
several by-products and 14-15 obtained were reacted 
directly with the N, N-dimethylethylene diamine to obtain 
carboxamides at C-4 at 0°C to preserve the chloride at C-
9 where a polyamine had to be attached in subsequent 
step. The protection of the secondary amino groups in 
spermine was easily effected using the procedure from 
the literature in a very good yield (Geall et al., 2000). The 
1H NMR spectrum confirmed the presence of the Boc 
groups with a characteristic tertiary butyl signal at 1.42 
ppm which intergrated to 27 hydrogens. The methylene 
protons appeared in the region of 3.24-3.35 ppm. 13C 
NMR analysis also confirmed the structure of 18 showing 
a distinctive signal at 28.7 ppm for the methyl carbons of 
the boc group and a carbamate signal at 155.5 ppm. 
The amine conjugates of the acridines were synthe-
sized by heating the tribocspermine with the derivatized 
acridines and very good yields were obtained Deprotec-
tion of spermine-acridine conjugates was rapidly carried 
out using TFA. Previously documented methods using a 
hydrobromic acid/acetic acid mixture was abandoned 
because acetic acid could neither be eliminated in vacuo 
or by phase separation (Kunze, 1996; Zheng et al., 
2000). The purification of the resultant conjugates could 
not be done on conventional column chromatography 
material such as silica gel or alumina because the 
polyamine   moiety  strongly  adhered   to  the  silica   and  
 
 
 
 
attempts to purify them on alumina resulted in a conti-
nuous streak making separation impossible. DOWEX, a 
cation exchange resin, which is widely used in the 
separation of peptides was adopted as a stationary 
phase and isopropanol and water as mobile phase for a 
gravity column. This afforded pure hydrochloride salts of 
the conjugates. The NMR spectra of all three compounds 
showed the absence of the Boc groups. As expected, the 
signals for the NH and NH2 were not observed since D2O 
was used as the solvent. The signals for the aromatic 
protons were observed in the expected region downfield. 
The hydoxyl deprotection of the methoxyacridine conju-
gate 28 was attempted using several methods. Deme-
thylation attempts were made using boron tribromide 
(Spence et al., 2003) and pyridine hydrochloride salts 
(Kirkiacharian et al., 2002) under various conditions 
without success. The methoxy derivative 27 was suc-
cessfully demethylated by reaction with sodium ethane-
thiolate. This reaction proceeded at a temperature of 
about 100°C for 3 h in DMF and this method is preferred 
since it does not affect other functional groups present in 
the molecule (Linderberg et al., 2004). Synthesis of the 
amide-linked acridine-spermine conjugates using cou-
pling agents such as DCC, EDAC and PyBOP with the 
addition of catalytic amounts of HOBt was not successful 
even under stringent dry conditions suggested in the 
literature. Due to the problems encountered with the 
coupling agent method, the acid functionality was 
converted to the acyl chloride with thionyl chloride which 
was further reacted immediately with protected spermine 
in the presence of catalytic quantities of DIPEA. This 
method was uncomplicated and was complete within a 
short period of time with a relatively good yield of product 
even though it had to be stopped within 2 h, to avoid the 
generation of hydrochloric acid which may deprotect both 
tri-Boc-spermine and the spermine-acridine conjugate 
leading into the formation of by-products, including a bis-
acridine-spermine conjugate. For the synthesis of the 
trifunctional compounds, the first strategy was to join two 
precursors namely androsterone 33 and dibocspermine 
19. 
The molar equivalents of di-Boc-spermine and andro-
sterone 33 to limit reaction on single amino group 
exclusively were reductively aminated by using Borane-
Pyridine (BAP) (Rastogi et al. 2006) which worked very 
well to produce the product in sufficient quantities. The 1H 
NMR spectrum showed the presence of the Boc groups 
as well as a crowded region around 0.7-2.1 ppm, charac-
teristic for the androgen moiety. Similarly, the aliphatic 
region of the 13C NMR spectrum was busy, and all the 
expected signals were present. The free amine of the 
androsterone-di-Boc-spermine conjugate 34 was reacted 
successfully with phenoxy acridine 3 to obtain unconta-
minated trifunctional target molecule. Both 13C and 1H 
NMR spectroscopy confirmed the structure of the 
product. The signals for the aromatic ring appeared at 
8.31, 8.12 and 7.53  in  the  1HNMR  spectrum  and  there  
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Table 1. In vitro cytotoxic activity against LNCaP and PC3 cell lines 
 
Compounds AR+ LNCaP IC 50 (µM) AR- PC3 IC50 (µM) 
27 1.51 (0.00275) 1.00 
28 0.6 (0.00112) 3.04 
32 >10 >10 
25 0.18 0.98 
26 0.36 2.04 
36 0.6 1.01 
 
 
 
were peaks in the region 3.35-1.75 ppm corresponding to 
the polyamine. The signals for the steroid were 
overlapping between 0.64-2.10 ppm. The 13C NMR 
spectrum contained peaks at 154 ppm for the carbonyl of 
the protecting group and there were five aromatic ring 
signals around 151.6-116.1 ppm. The signals for the 
steroid were in the expected region of the spectrum. 
Deprotected product by TFA 35 was purified by 
recrystallization whereby the residue was warmed with 
acetonitrile and left overnight to give product 49 as a 
yellow solid which was recrystallized from ethanol. MS, 
NMR, and IR analysis were consistent with the structure. 
Cytotoxicity studies where carried out and results are as 
they appear in Table 1 
 
 
Cytotoxic studies 
 
Two cell lines were selected for study; the LNCaP cell 
lines which are androgen sensitive and PC3 that are 
androgen insensitive. Table 1 displays the activity of the 
6 compounds screened. All six compounds 27, 28, 32, 
25, 26 and 36 showed activity against both cell lines. 
Compounds that have close chemical structure have 
demonstrated structural relationship to their cytotoxic 
activities. Compound 27 and 28 which only differ by 
having a methoxy and hydroxyl substituent respectively, 
have shown this relationship. The removal of a methoxyl 
group increased activity by about 3-fold. This might be 
contributed by the hydrophilicity added by the methoxy 
group cleavage. Compound 27 displayed superior activity 
on PC3 than LNCaP while 28 showed a 5-fold decrease 
in activity in the androgen independent cell line PC3. 
Compounds 25 and 26 also showed this kind of 
relationship. The presence of the methyl group at C-5 
halved the activity on androgen dependent cell lines. The 
same compounds had their activity depressed five folds 
on the androgen independent cell lines. This trend is in 
agreement with that observed for compound 28.  
However, compound 36 as expected, showed potency 
on LNCaP and this potency was lowered by 1.67 folds on 
androgen independent cells PC3. This trend may suggest 
that hydrophilic substituents are favourable while 
hydrophobic are detrimental for the activity. The addition 
of an androgen moiety at the acridine-spermine conju-
gate, which  made  the  36,  produced  the  activities  that 
were equally potent and similar to 28. 
 
 
Conclusion 
 
In this study, six compounds have been designed and 
synthesized and one of them was trifunctional. These 
compounds were all tested against androgen dependent 
and androgen independent prostate cancer cell lines. All 
of them, with the exception of one compound, were 
equally cytotoxic to both cell lines and have shown to be 
effective inhibitors of prostate cancer cells in vitro. The 
trifunctional compound was active against androgen 
dependent cell lines, while that activity was halved to 
androgen-independent cells. Efforts are underway to 
understand the structure- activity relationship to obtain 
the most optimal compounds. 
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